Testing a radioactive PSMA scan for brain tumor surgery planning
Part of Cancer clinical trials.
This study tests whether a special radioactive scan that targets PSMA can help identify a high-grade brain tumor in people who are about to have surgery. It may help doctors better target treatment by confirming the tumor’s PSMA features using a radiolabeled imaging approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be scheduled to have brain surgery (biopsy or removal) for a suspected high-grade primary brain tumor
- Have had imaging work-up to check the cancer is not metastatic (spread) elsewhere
- Be able to sign informed consent (or be able to provide consent)
- Be able to safely have MRI contrast and the radioactive tracer used in the scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
This trial tests if a special scan (PSMA-PET) can help plan surgery for melanoma that has spread to lymph nodes. It may help doctors remove all cancer more accurately.
This study looks at MRI scans to find “molecular markers” that may reflect how active a brain tumor is. If you’re having surgery for a primary brain tumor, these scan results may help researchers better understand tumor behavior.
This trial tests whether using a special PET scan (a type of imaging that shows tumor activity) during brain tumor surgery helps doctors remove more of the tumor safely. You would have a high-grade glioma (an aggressive brain cancer) and be scheduled for surgery.
This trial tests a special imaging scan called Ga-68 PSMA-11 PET/CT to see if it can better detect when a glioma brain tumor has come back or progressed. It is for people who have already had standard treatment and are planning surgery for a suspected recurrence.
This trial tests how well a special PET/MRI scan can help doctors evaluate gliomas and brain metastases. It may help improve diagnosis and treatment planning by comparing scan results with tissue samples or surgery findings.
Hear when a new Glioma, Malignant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.